Larimar Therapeutics, Inc. (LRMR) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 277.93M |
| Enterprise Value | 196.59M |
| P/E Ratio | -1.49 |
| PEG Ratio | 0.05 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 2.41 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.28 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -1.04 |
| Return On Equity | -1.37 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -165.32M |
| Net Income | -165.67M |
| Diluted EPS | -2.27 |
Balance Sheet
| Total Cash | 156.27M |
| Total Cash/Share | 1.5 |
| Total Debt | 4.96M |
| Total Debt/Equity | 0.04 |
| Current Ratio | 4.7 |
| Book Value Per Share | 1.23 |
Price History
| 52-Week Change | -30.84 |
| 52-Week High | 6.42 |
| 52-Week Low | 2.72 |
| Moving Average 50 Days | 3.9 |
| Moving Average 200 Days | 3.93 |
Statistics
| Average Volume | 1.36M |
| Shares Outstanding | 103.88M |
| % Held by Institutions | 92.37 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | May 29, 2020 |
AD
